Charting the "Splice" Routes to MDS
- PMID: 25965565
- DOI: 10.1016/j.ccell.2015.04.016
Charting the "Splice" Routes to MDS
Abstract
Mutations in components of the 3' mRNA splicing machinery are found in almost 50% of myelodysplastic syndrome (MDS) cases. In this issue of Cancer Cell, Kim and colleagues, Colla and colleagues, and Shirai and colleagues report on the impact of mutated or dysregulated splicing factors to hematopoiesis, mRNA splicing, and MDS pathogenesis.
Copyright © 2015 Elsevier Inc. All rights reserved.
Comment on
-
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.Cancer Cell. 2015 May 11;27(5):617-30. doi: 10.1016/j.ccell.2015.04.006. Cancer Cell. 2015. PMID: 25965569 Free PMC article.
-
Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.Cancer Cell. 2015 May 11;27(5):631-43. doi: 10.1016/j.ccell.2015.04.008. Cancer Cell. 2015. PMID: 25965570 Free PMC article.
-
Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome.Cancer Cell. 2015 May 11;27(5):644-57. doi: 10.1016/j.ccell.2015.04.007. Cancer Cell. 2015. PMID: 25965571 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
